Brauner E, Ioan E, Turcu T, Mihalache D, Hurmuzache T, Feller H, Cercel I, Iosefsohn J, Cohn E
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1977 Jan-Mar;22(1):17-21.
A group of 39 former dysentery patients, who continued to excrete Shigella bacteria after a first cure of antibiotics when full clinical recovery was obtained, were treated differentially under bacteriological control. The carrier state was still extent in 7% of the cases after three antibiotic or chemotherapeutical cures. No direct relation was found between the sensitivity of Shigella to chemotherapeutics and the level of the carrier state. Although treated already in the acute stage with adequate antibiotics, resistance to a second therapeutical attempt was recorded in a proportion of 33%. It is considered useless to repeat the antibiotic or chemotherapeutical cures in the treatment of convalescent carriers because of the low efficiency and the biological and economical disadvantages.
一组39名曾患痢疾的患者,在首次使用抗生素治愈且临床完全康复后仍继续排出志贺氏菌,在细菌学控制下对他们进行了差异化治疗。经过三次抗生素或化疗治愈后,仍有7%的病例处于带菌状态。未发现志贺氏菌对化疗药物的敏感性与带菌状态水平之间存在直接关系。尽管在急性期已使用足够的抗生素进行治疗,但仍有33%的患者对第二次治疗尝试产生了耐药性。由于效率低下以及生物学和经济方面的劣势,在治疗恢复期带菌者时重复使用抗生素或化疗被认为是无用的。